
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Identification of a five genes prognosis signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis
Jiulong Ma, Chen Chen, Shan Liu, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 11, pp. 1578-1589
Closed Access | Times Cited: 28
Jiulong Ma, Chen Chen, Shan Liu, et al.
Cancer Gene Therapy (2022) Vol. 29, Iss. 11, pp. 1578-1589
Closed Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
Spindle apparatus coiled‐coil protein 1 (SPDL1) serves as a novel prognostic biomarker in triple‐negative breast cancer
Xian‐yan Yang, Xiaoxia Zheng, Xuejia Zhai, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 4
Closed Access | Times Cited: 4
Xian‐yan Yang, Xiaoxia Zheng, Xuejia Zhai, et al.
PROTEOMICS - CLINICAL APPLICATIONS (2024) Vol. 18, Iss. 4
Closed Access | Times Cited: 4
Association of IL-1β gene polymorphisms rs1143627, rs1799916, and rs16944 with altered risk of triple-negative breast cancer
Ikram Sghaier, Jordan M. Sheridan, Amira Daldoul, et al.
Cytokine (2024) Vol. 180, pp. 156659-156659
Closed Access | Times Cited: 4
Ikram Sghaier, Jordan M. Sheridan, Amira Daldoul, et al.
Cytokine (2024) Vol. 180, pp. 156659-156659
Closed Access | Times Cited: 4
Molecular genetic predictors of progression of triple negative breast cancer
I. S. Panchenko, В. В. Родионов, В. В. Кометова, et al.
Siberian Journal of Oncology (2025) Vol. 24, Iss. 1, pp. 70-78
Open Access
I. S. Panchenko, В. В. Родионов, В. В. Кометова, et al.
Siberian Journal of Oncology (2025) Vol. 24, Iss. 1, pp. 70-78
Open Access
Engineered nanovesicles targeting SERPINE1 overcome temozolomide resistance in glioblastoma
Jianping Wen, Ding Wen Wu, Yi Le, et al.
Cellular Signalling (2025), pp. 111763-111763
Closed Access
Jianping Wen, Ding Wen Wu, Yi Le, et al.
Cellular Signalling (2025), pp. 111763-111763
Closed Access
Hsa_circ_0072088 promotes non-small cell lung cancer progression through modulating miR-1270/TOP2A axis
Sixuan Li, Zhigang Cui, Min Gao, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Sixuan Li, Zhigang Cui, Min Gao, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Gene expression profile analysis to discover molecular signatures for early diagnosis and therapies of triple-negative breast cancer
Md Shahin Alam, Adiba Sultana, Guanghui Wang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 17
Md Shahin Alam, Adiba Sultana, Guanghui Wang, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 17
Identification of Hub Genes Associated with Breast Cancer Using Integrated Gene Expression Data with Protein-Protein Interaction Network
Murtada K. Elbashir, Mohanad Mohammed, Henry Mwambi, et al.
Applied Sciences (2023) Vol. 13, Iss. 4, pp. 2403-2403
Open Access | Times Cited: 10
Murtada K. Elbashir, Mohanad Mohammed, Henry Mwambi, et al.
Applied Sciences (2023) Vol. 13, Iss. 4, pp. 2403-2403
Open Access | Times Cited: 10
MASP1 modulation as a novel therapeutic target in severe pediatric pertussis: insights from a multi-omics approach
Lin Xu, Caiying Wang, Yuhuan Liu, et al.
Infection and Immunity (2025)
Closed Access
Lin Xu, Caiying Wang, Yuhuan Liu, et al.
Infection and Immunity (2025)
Closed Access
Nanocrystalline cellulose-geniposide complex enhances gut-brain axis modulation for depression treatment
Tianyu Zou, Xiang D. Tang, Hai‐Ping Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
Tianyu Zou, Xiang D. Tang, Hai‐Ping Wang, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access
An engineered niche delineates metastatic potential of breast cancer
Sophia M. Orbach, Christian Y. DeVaull, Elizabeth Bealer, et al.
Bioengineering & Translational Medicine (2023)
Open Access | Times Cited: 8
Sophia M. Orbach, Christian Y. DeVaull, Elizabeth Bealer, et al.
Bioengineering & Translational Medicine (2023)
Open Access | Times Cited: 8
Identification and validation of a 17-gene signature to improve the survival prediction of gliomas
Shiao Tong, Minqi Xia, Yang Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
Shiao Tong, Minqi Xia, Yang Xu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 11
High expression of hypoxia-inducible factor 1-alpha predicts poor prognosis in pancreatic ductal adenocarcinoma: a meta-analysis and database validation protocol
Alexis Zoa, Yingjie Yang, Wenjin Huang, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 9, pp. 3080-3091
Open Access | Times Cited: 11
Alexis Zoa, Yingjie Yang, Wenjin Huang, et al.
Translational Cancer Research (2022) Vol. 11, Iss. 9, pp. 3080-3091
Open Access | Times Cited: 11
Identification of key genes and pathways in adrenocortical carcinoma: evidence from bioinformatic analysis
Mengsha Yin, Yao Wang, Xinhua S. Ren, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Mengsha Yin, Yao Wang, Xinhua S. Ren, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell data
Zeyu Xing, Dongcai Lin, Yuting Hong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Zeyu Xing, Dongcai Lin, Yuting Hong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Sisi Gong, Zhijun Liao, Meie Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Sisi Gong, Zhijun Liao, Meie Wang, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 1
Elucidating the Prognostic and Therapeutic Significance of TOP2A in Various Malignancies
Guangchao Liu, Wenlong Lin, Kaifeng Zhang, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 68-81
Closed Access | Times Cited: 1
Guangchao Liu, Wenlong Lin, Kaifeng Zhang, et al.
Cancer Genetics (2024) Vol. 288-289, pp. 68-81
Closed Access | Times Cited: 1
Deciphering the prognostic landscape of triple‐negative breast cancer: A focus on immune‐related hub genes and therapeutic implications
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Biotechnology and Applied Biochemistry (2024)
Open Access | Times Cited: 1
HemaNandini Rajendran Krishnamoorthy, K. Ramanathan
Biotechnology and Applied Biochemistry (2024)
Open Access | Times Cited: 1
The crucial prognostic signaling pathways of pancreatic ductal adenocarcinoma were identified by single-cell and bulk RNA sequencing data
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Human Genetics (2024)
Open Access | Times Cited: 1
Wenwen Wang, Guo Chen, Wenli Zhang, et al.
Human Genetics (2024)
Open Access | Times Cited: 1
Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer
Qing Xin, Chunlei Yuan, Ke Wang
Breast Cancer (2023) Vol. 30, Iss. 3, pp. 424-435
Closed Access | Times Cited: 2
Qing Xin, Chunlei Yuan, Ke Wang
Breast Cancer (2023) Vol. 30, Iss. 3, pp. 424-435
Closed Access | Times Cited: 2
Overcoming Breast Cancer Resistance to Targeted, Chemo-, and Immuno Therapy: Mechanisms and Strategies to Overcome Resistance and Facilitate Drug Development
Adam Hermawan, Sisca Ucche, Wilfan Ibadurrahman, et al.
(2024), pp. 377-431
Closed Access
Adam Hermawan, Sisca Ucche, Wilfan Ibadurrahman, et al.
(2024), pp. 377-431
Closed Access
Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan’s National Database
Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 792-792
Open Access
Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, et al.
Genes (2024) Vol. 15, Iss. 6, pp. 792-792
Open Access
Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer
Sisi Gong, Rongfu Huang, Meie Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
Sisi Gong, Rongfu Huang, Meie Wang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access
ITGB4/GNB5 axis promotes M2 macrophage reprogramming in NSCLC metastasis
Xiaofeng Huang, Guiping Yu, Xuewei Jiang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113564-113564
Closed Access
Xiaofeng Huang, Guiping Yu, Xuewei Jiang, et al.
International Immunopharmacology (2024) Vol. 144, pp. 113564-113564
Closed Access
Deciphering the miRNA–mRNA Interaction Landscape between Breast Cancer and Triple-Negative Breast Cancer: An Integrated Bioinformatics Approach
Ambritha Balasundaram, Tanisha Saurav Mitra, Iftikhar Aslam Tayubi, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 24379-24395
Open Access
Ambritha Balasundaram, Tanisha Saurav Mitra, Iftikhar Aslam Tayubi, et al.
ACS Omega (2024) Vol. 9, Iss. 23, pp. 24379-24395
Open Access
Elevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer
Xiang‐Guang Wu, Yu Wu, Yu-Hua Pan, et al.
Gene (2024) Vol. 927, pp. 148756-148756
Closed Access
Xiang‐Guang Wu, Yu Wu, Yu-Hua Pan, et al.
Gene (2024) Vol. 927, pp. 148756-148756
Closed Access